AI assistant
Sending…
Vitrolife — Major Shareholding Notification 2017
Nov 10, 2017
2989_iss_2017-11-10_92db443f-1b52-438c-b7ee-5df0ec21213a.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Vitrolife AB
Holder
William Demants og Hustru Ida Emilies Fond - kaldet Oticon-fonden
Instrument
| Instrument | Shares SE0000816043 |
|---|---|
| Before the transaction | |
| Shares | 4,293,644 |
| Voting rights | 4,293,644 |
| Transaction | |
| Reason for major shareholding notification Buy | |
| Date | 08/11/2017 |
| Limit for number of shares | 20 % |
| Limit for number of votes | 20 % |
| After the transaction | |
| Quantity | |
| Shares | 4,688,064 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 4,688,064 |
| Percentage | |
| Directly held shares | 21.59 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 21.59 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 21.59 % | 4,688,064 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 21.59 % | 4,688,064 |
Chain of controlling companies
| Voting rights |
% Voting rights |
Company | ||
|---|---|---|---|---|
| 0 | 0 | William Demants og Hustru Ida Emilies Fond - kaldet Oticon fonden |
||
| 4,688,064 21.59 | William Demant Invest A/S | |||
| Group total holdings | ||||
| Voting rights | 4,688,064 | |||
| Percentage of voting rights 21.59 |
Published
| 10/11/2017 13:07 | ||||
|---|---|---|---|---|
| Contact | ||||
| Name | Pelle Munk-Poulsen | |||
| Phone | +4539177300 | Email [email protected] |
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Vitrolife
Board/Management Information
2026
May 22
Board/Management Information
2026
May 22
AGM Information
2026
May 5
AGM Information
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Board/Management Information
2026
Apr 1
Board/Management Information
2026
Apr 1
Annual Report
2026
Mar 26
Annual Report
2026
Mar 26